Articles tagged with Respiratory Disorders
Researchers identified specific antibody features that limit Mtb growth, revealing critical insights into antibody-immune cell interactions. The study lays groundwork for potential antibody-based therapies or vaccines against tuberculosis, an urgently needed treatment for the deadly infectious disease.
A new study found that routine testing for multiple infectious diseases among migrants can identify key infections earlier, improving health outcomes and reducing onward transmission. The Leicester screening programme, which tested 4004 migrant patients, revealed new diagnoses of TB, Hepatitis B and C, and HIV.
Exposure to lingering fine particulate matter from wildfire smoke was associated with increased hospitalization risks for various cardiorespiratory conditions, including ischemic heart disease and respiratory diseases. The study's findings highlight the need for research into the long-term health impacts of wildfire smoke.
A new study reveals that the weight of fathers during adolescence can harm genes in future children, linked to asthma, obesity, and low lung function. The effect is more pronounced in female children, highlighting a potential vulnerability window for lifestyle influences.
A computerized decision support tool reduced the time children with lung failure spent on ventilation by shortening weaning time and improving respiratory muscle strength. The intervention group had better functional status at ICU discharge than the control group.
Researchers discovered a DNA switch in TB bacteria that regulates growth and gene expression. By targeting this process, new antibiotics could be developed to make the bacteria easier to eliminate.
An international team of researchers has identified a genetic link to long-term symptoms after COVID-19, with a gene variant increasing the risk by about 60%. The variant is located near the FOXP4 gene, which affects lung function and development. Impaired lung function plays a key role in developing long COVID.
The Cleveland Clinic has been awarded a $5 million grant from the Cystic Fibrosis Foundation to continue its role as the Biorepository Coordinating Center for the Cystic Fibrosis Lung Transplant Consortium until 2030. The center will support research to improve understanding of factors affecting lung transplant outcomes and advance kno...
Researchers will present AI models that predict chronic respiratory failure and detect airway obstruction, with key findings on asthma susceptibility, small airway disease, and lung inflammation. The studies use nasal epithelial gene expression analyses and bronchoscopy to identify potential biomarkers for ICU patient outcomes.
New research found that inhaled microplastics inhibit tissue maintenance functions of pulmonary macrophages. The findings suggest that exposure to microplastics can lead to long-term disruption of immune function and increase risk of cancer and other diseases.
A new study found that ciliary dynamics play a significant role in the pathophysiology of bronchopulmonary dysplasia, with more severe cases showing distinct ciliary beat abnormalities. The study provides new insights into BPD mechanisms and potential therapeutic targets.
Under the new Composite Allocation Score (CAS) system, lung transplant waitlisted patients experienced lower mortality rates, particularly among the sickest patients. The CAS prioritizes medical urgency and other patient factors, leading to a 11.2% decrease in waitlist deaths from 2017 to 2023.
Researchers found methotrexate to be non-inferior to prednisone in controlling pulmonary sarcoidosis after 24 weeks of treatment, but had a slower onset of efficacy. The study suggests an alternative first-line treatment for patients with pulmonary sarcoidosis who want to avoid steroid side effects.
A new COPD diagnostic approach integrates respiratory symptoms, quality of life, spirometry, and CT imaging to accurately classify individuals with the disease. This framework reveals increased risks for mortality, exacerbations, and lung function decline among those classified as having COPD.
Key findings reveal oxidative stress as a prominent area in COPD studies, with hot topics including air pollution, cigarette smoke extract, and mitochondrial dysfunction. The study highlights the need for targeted antioxidants to effectively treat COPD.
Researchers developed a nomogram to predict pulmonary embolism (PE) in patients with pulmonary tuberculosis (PTB), showing strong clinical applications. The model's probabilities were close to actual values, indicating improved early diagnosis and timely intervention.
A study by National Center for Respiratory Medicine identified upper airway cough syndrome (UACS) as a key characteristic of early responders to chronic cough treatment. Higher baseline cough numeric rating scale (NRS) scores were also associated with early response, suggesting shorter treatment durations may be considered.
This observational study found that bronchoscopic lung volume reduction with endobronchial valves under moderate sedation has a lower rate of complications, particularly pneumothorax, compared to general anesthesia. The procedure can be safely performed with similar efficacy as demonstrated in previous studies.
A study analyzing national health insurance data found that severe adult asthma increases the risk of chronic diseases, including cardiovascular and cerebrovascular diseases. This highlights the importance of considering comorbidities when managing asthma patients.
The study found that 18F-FAPI-04 PET/CT had higher maximum standardized uptake value and tumor-to-background ratio compared to 18F-FDG PET/CT for stage IA lung adenocarcinoma. This suggests that 18F-FAPI-04 PET/CT may be more effective in detecting stage IA lung adenocarcinoma lesions.
Researchers found distinct monthly dynamics in primary spontaneous pneumothorax incidence by age group, with BMI and monocyte-lymphocyte ratio as key risk factors for recurrence. The study highlights the importance of investigating PSP epidemiology and risk factors.
Activating Nrf2 reduces senescent bronchial epithelial cells, improving lung function and decreasing inflammation in COPD models. This novel therapeutic approach targets cellular senescence and inflammation to mitigate COPD progression.
A single center case series reports increased vulnerability of lung transplant recipients to severe disease and combined infections after Omicron infection. High-risk factors include elevated CRP levels, interstitial lung disease, and low CD4+ T lymphocyte count.
The study found that cone-beam CT-guided bronchoscopy has a high diagnostic yield of 80.2% for peripheral pulmonary lesions, with subgroup analysis showing higher yields for larger lesions and those with the bronchus sign. The procedure was also associated with low adverse event rates.
Research reveals individuals taking oral steroids for over 3 months are 6 times more likely to be diagnosed with adrenal insufficiency than those treated with non-steroidal anti-inflammatory drugs. Long-term users of inhaled steroids also face increased risk without hospitalisations.
A major study found that taking the progesterone-only pill can increase asthma attacks in some women, especially those under 35 and using fewer asthma treatments. Women with eosinophilic asthma were also at a higher risk. The research aims to better understand why women are more likely to have severe asthma than men.
Researchers found daily increases of 11-24% in asthma-related emergency department visits over the first episode of a wildfire event, continuing up to 6 days after it ended. However, a second period of heavy smoke did not result in an increase in asthma-related ED visits.
Researchers have developed a method to label and visualize the glycans in Mycobacterium tuberculosis cells, which may lead to faster and cheaper diagnostic tests for TB. The approach uses an organic molecule that reacts with specific sulfur-containing sugars found in only three bacterial species, including M. tuberculosis.
Researchers developed a novel rat model that closely replicates human COPD-associated cor pulmonale, exhibiting chronic lung inflammation, pulmonary hypertension, and right ventricular hypertrophy. The model provides insights into the underlying mechanisms of disease progression and potential therapeutic targets.
Researchers at Karolinska Institutet have identified biomarkers in the blood associated with long COVID symptoms, particularly severe respiratory disorders. The study found that these biomarkers are also linked to inflammatory signal pathways involved in cell death and lung damage.
Exposure to high levels of smoke pollution increases hospitalizations for respiratory diseases in older adults. The study highlights the need for interventions to mitigate the health impacts of wildfire smoke exposure.
A new global clinical trial has demonstrated the benefits of an investigational medication called brensocatib, a DPP-1 inhibitor, in improving bronchiectasis patients' quality of life. The study showed that nearly half of patients remained exacerbation-free one year later and experienced significant improvements in lung function.
A Phase Ia/Ib trial found that zongertinib demonstrated clinical benefits for patients with advanced HER2-mutant non-small cell lung cancer, particularly those with specific HER2 mutations. The treatment showed a 71% objective response rate and manageable side effects.
A study on donor lungs preserved outside the body demonstrated that HOPE is a safe and effective method for lung preservation, with no rejections and similar short-term outcomes compared to direct transplantation. The study found that extending perfusion times can optimize donor lungs for future therapies.
Researchers at Tulane University identified a potential new way to treat idiopathic pulmonary fibrosis (IPF) using an FDA-approved cancer drug. The treatment works by blocking the CTLA4 protein, which blocks overactive T cells, allowing the immune system to clear out damaged cells that cause lung scarring.
A multi-state study found that only half of high-risk adults with flu received antiviral treatment, highlighting a critical need for timely care. The gap in treatment increases the risk of severe flu complications, particularly among older adults and those with underlying conditions.
Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare disease causing chronic hoarseness and breathing difficulties in children. New clinical guidelines provide actionable recommendations for early recognition, diagnosis, and treatment to improve long-term outcomes.
Severe RSV disease among children is more likely those aged 2 or older with pulmonary or neurologic conditions. Younger children under 6 months and prematurity are high-risk factors for severe RSV in younger kids.
The article explores how DeepSeek's advanced language model can enhance ARDS management by detecting signatures earlier and with greater precision, identifying distinct phenotypes, and providing personalized treatment strategies. This could lead to improved patient outcomes and reduced mortality rates.
A literature review found that weak coughs increase the risk of extubation failure and prolonged hospitalization. Employing individualized cough exercises, such as increasing inhaled volume and utilizing oscillation techniques, can significantly improve patient outcomes.
Scientists discovered a protein called HARS WHEP that calms inflammation in lung diseases by regulating white blood cells. The treatment efzofitimod showed promising results in reducing inflammation and fibrosis, providing new hope for patients suffering from sarcoidosis.
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed in Elsevier's Scopus database. This achievement is a testament to the high-quality research published in these journals, which provide open access content in pulmonary and critical care medicine.
A cross-sectional study found that hospitalized adults with RSV vaccine eligibility were more likely to receive the vaccine. Sociodemographic differences in vaccine uptake occurred, suggesting appropriate prioritization of populations with increased risk.
Research shows that highly reactive components in particulate matter disappear within hours, leading to inaccurate estimates of their presence and potential health risks. This discovery highlights the need for more accurate measurements and better protective measures.
The American Thoracic Society's ATS 2025 International Conference will showcase cutting-edge research in pulmonary, critical care, and sleep medicine. The conference will include breaking news from leading experts in the field.
Researchers at Karolinska Institutet have developed a new method to diagnose COPD by analyzing protein levels in nasal lavage. The study found that elevated IL-26 levels can indicate an early phase of the disease, and may lead to new treatment strategies targeting this cytokine.
Researchers discovered that misplaced immune cells drive aggressive lung disease, with potential for new treatments targeting plasma cells and their signaling pathways. The study found novel cellular networks orchestrating the abnormal immune response, offering hope for patients with limited therapeutic options.
Researchers have discovered a potential new treatment for pulmonary fibrosis by targeting the Piezo2 receptor, which plays a critical role in stiffness-mediated profibrotic fibroblast phenotypes. Inhibiting Piezo2 expression or function may slow disease progression and offer new therapeutic options.
Researchers at WashU have developed a method to manipulate the mechanical side of fibrosis, a complex condition that can lead to scarring and breathing difficulties. By controlling the direction of tension forces, they aim to prevent or treat fibrosis and develop personalized treatment plans for patients.
A new editorial highlights a growing concern in cancer care: radiotherapy may leave behind residual disease that can lead to worse long-term outcomes. Studies have shown that patients with residual disease are more likely to experience cancer recurrence and shorter survival, emphasizing the need for regular biopsy-based tests.
Crew-9 astronauts conducted research on protein crystallization studies and a new drug for Alzheimer's, dementia, and Parkinson's. They also supported student-led experiments, contributing to the next generation of explorers.
CHEST MedCast offers over 400 videos and podcasts with personalized content recommendations, available on-demand and at any time from any device. The platform features an algorithm-based recommendation engine and up to 100 available CME credits/MOC points.
A new study led by University College London researchers found that social disadvantages can accelerate ageing and increase disease risk. People with favourable socioeconomic conditions show fewer signs of biological ageing than peers of the same age.
Researchers have discovered how severe COVID-19 can destroy immune cells' ability to repair the lungs, leading to lingering effects of long COVID. By enhancing damaged organelles using a FDA-approved drug, they found improved lung healing and reduced inflammation.
The Bronchiectasis and NTM Care Center Network facilitates access to specialized care and support for hundreds of thousands of people with bronchiectasis and NTM lung disease. The network aims to improve quality of life and advance a cure for these conditions.
Rentosertib, a breakthrough drug candidate for idiopathic pulmonary fibrosis (IPF), has been granted an official generic name by the USAN Council. The drug's development was accelerated using generative AI, identifying TNIK as a promising target and designing small-molecule compounds in just 18 months.
A breakthrough CRISPR-based test has been developed to diagnose Pneumocystis jirovecii pneumonia (PJP), a life-threatening fungal infection. The test detects RNA from live fungi in blood samples and throat swabs, providing a faster and more accurate diagnosis than current invasive bronchoscopy procedures.
The collaboration aims to close gaps in early recognition and management of IPF by equipping healthcare providers, public health professionals, and patients with necessary resources. The organizations will employ designated activities to build a knowledge base, develop survey tools, and create educational and awareness assets.
A nationwide study found that COVID-19 hospital patients experienced a higher rate of deaths from any cause and were more likely to be hospitalized for specific conditions, particularly neurological and respiratory problems. The study also identified increased risks of chronic health complications up to 30 months after discharge.
A study suggests that pre-existing immunity against seasonal H1N1 flu can reduce the severity of bird flu in ferrets. In the study, ferrets with prior H1N1 immunity were protected against severe disease and death caused by H5N1 bird flu, whereas those without prior immunity had more severe illness and fatal outcomes.